Children are not just small adults: The urgent need for high-quality trial evidence in children

PLoS Medicine

Volumn 5, Issue 8, 2008, Pages 1180-1182

  Klassen, Terry P ^a   Hartling, Lisa ^a   Craig, Jonathan C ^b   Offringa, Martin ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PLACEBO;

CHILD HEALTH; CLINICAL TRIAL; CONFIDENCE INTERVAL; EPILEPSY; HOSPITALIZATION; HUMAN; NEUROLOGIC DISEASE; REVIEW; STATISTICAL SIGNIFICANCE; ADULT; CHILD; CLINICAL TRIAL (TOPIC); NOTE; STANDARD;

ADULT; CHILD; CLINICAL TRIALS AS TOPIC; EPILEPSY; HUMANS; PLACEBOS;

EID: 50949115424     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050172     Document Type: Review

References (17)

1. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, et al. (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 320: 79-82.
2. 't Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, et al. (2000) Unapproved and off-label use of drugs in a children's hospital. N Engl J Med 343:1125.
3. Cramer K, Wiebe N, Moyer V, Hartling L, Williams K, et al. (2005) Children in reviews: methodological issues in child-relevant evidence syntheses. BMC Pediatr 5: 38.
4. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, et al. (2003) Developmental pharmacology-Drug disposition, action and therapy in infants and children. N Engl J Med 349: 1157-1167.
5. Caldwell PHY, Murphy SB, Butow PN, Craig JC (2004) Clinical trials in children. Lancet 364: 803-811.
6. Johnson TN (2003) The development of drug metabolizing enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192: 37-48.
7. Garson A Jr. (1987) Medicolegal problems in the management of cardiac arrhythmias in children. Pediatrics 79: 84-88.
8. Bosch X (2005) Europe follows U.S. in testing drugs for children. Science 309: 1799.
9. Steinbrook R (2002) Testing medications in children. N Engl J Med 347: 1462-1470.
10. Benjamin DK Jr., Smith PB, Murphy MD, Roberts R, Mathis L, et al. (2006) Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA 296: 1266-1273.
11. Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, et al. (2007) Stimulation programs for pediatric drug research-Do children really benefit? Eur J Pediatr 166: 849-855.
12. Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P (2008) Greater response to placebo in children than in adults: A systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 5: e166. doi:10.1371/journal. pmed.0050166
13. Gidding SS (2007) The importance of randomized controlled trials in pediatric cardiology. JAMA 298: 1214-1215.
14. Cohen E, Uleryk E, Jasuja M, Parkin PC (2007) An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clinical Epidemiol 60: 118-123.
15. Martinez-Castaldi C, Silverstein M, Bauchner H (2008). Child versus adult research: The gap in high-quality study design. Pediatrics 122: 52-57.
16. Sammons HM, Gray C, Hudson H, Cherrill J, Choonara I (2008) Safety in pediatric clinical trials-A 7 year review. Acta Pediatr 97: 474-477.
17. Altman DG (1994) The scandal of pool-medical research. BMJ 308: 283-284.